АЛАРГОВА Россица Георгиева (US),ДАНБАР Крейг Энтони (US),КАДИЯЛА Ирина Николаевна (US)
申请号：
RU2013112937/15
公开号：
RU2013112937A
申请日:
2011.08.22
申请国别(地区):
RU
年份:
2014
代理人:
摘要：
1. A tablet for oral administration comprising: a. compound 1； b. filler； c. diluent； d. disintegrant； e. lubricant and f. glidant. 2. The tablet according to claim 1, where compound 1 is in the form of an amorphous form of compound 1.3. A tablet according to claim 1, wherein compound 1 or an amorphous form of compound 1 is present in said tablet in an amount of from about 1 mg to about 250 mg. A tablet according to claim 1, wherein compound 1 or an amorphous form of compound 1 is present in said tablet in an amount of from about 10 mg to about 250 mg. A tablet according to claim 1, wherein compound 1 or an amorphous form of compound 1 is present in said tablet in an amount of from about 25 mg to about 250 mg. The tablet according to claim 1, wherein compound 1 or an amorphous form of compound 1 is present in said tablet in an amount of from about 50 mg to about 200 mg. A tablet according to claim 1, wherein compound 1 or an amorphous form of compound 1 is present in said tablet in an amount of about 10 mg. A tablet according to claim 1, wherein compound 1 or an amorphous form of compound 1 is present in said tablet in an amount of about 50 mg. A tablet according to claim 1, wherein compound 1 or an amorphous form of compound 1 is present in said tablet in an amount of about 100 mg. The tablet according to claim 1, where the amount of compound 1 or an amorphous form of compound 1 in the specified tablet is in the range from about 1% of the mass. up to about 80% of the mass. based on the weight of the indicated tablet. 11. The tablet of claim 1, wherein the amount of compound 1 or an amorphous form of compound 1 in said tablet is in the range of about1. Таблетка для перорального введения, содержащая:а. соединение 1；b. наполнитель；с.разбавитель；d. дезинтегрант；е. лубрикант иf. глидант.2. Таблетка по п.1, где соединение 1 находится в виде аморфной формы соединения 1.3. Таблетка по п.1, где соединение 1 или аморфная форма соединения 1 присутствует в указанной таблетке в
